New eye drop could match current treatment for dry eye relief
NCT ID NCT05865457
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tests whether a new eye drop (BUFY02) works as well as an existing one (TRB02) for treating dry eye disease. About 80 people with dry eye for at least 3 months will use the drops daily for 3 months. Researchers will check eye health and symptoms to see if both treatments are similarly effective and safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU Brest
RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Nice
RECRUITINGNice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Bicêtre
RECRUITINGLe Kremlin-Bicêtre, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University Graz
RECRUITINGGraz, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
VIROS
RECRUITINGVienna, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.